This inventor holds 6 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Pfizer Corporation. Active years: 2012-2026.
Company Filing History:
Years Active: 2012-2026
Title: The Innovations of Qifang Li
Introduction
Qifang Li is a prominent inventor based in Stonington, CT (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for diacylglycerol acyltransferase 2 (DGAT2). With a total of five patents to his name, Li's work has the potential to impact the treatment of various diseases.
Latest Patents
Among his latest patents are compounds that inhibit the activity of diacylglycerol acyltransferase 2 (DGAT2). These compounds, described in detail in his patents, are aimed at treating diseases linked to this enzyme in animals. The innovative nature of these compounds showcases Li's commitment to advancing medical science.
Career Highlights
Qifang Li is currently associated with Pfizer Corporation, a leading pharmaceutical company. His role at Pfizer allows him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to the field.
Collaborations
Some of his notable coworkers include Markus Boehm and Shawn Cabral. Their collaborative efforts contribute to the innovative environment at Pfizer, fostering advancements in pharmaceutical research.
Conclusion
Qifang Li's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight the importance of teamwork in advancing medical treatments.